A drug now prescribed for cardiovascular problems could become a new tool in physicians’ arsenals to attack certain types of leukemia that so far have evaded effective treatments, researchers say.
A drug now prescribed for cardiovascular problems could become a new tool in physicians’ arsenals to attack certain types of leukemia that so far have evaded effective treatments, researchers say.